Cochlear gene therapy represents a potential experimental and therapeutic tool to understand and treat deafness. In designing cochlear gene transfer studies, the chosen route of delivery of vector and the choice of gene therapy vector have to be given careful consideration. Several different routes of delivery have been tested in our laboratory including infusion with osmotic minipump, direct microinjection into the cochlea and application of vector-transgene complex-soaked Gelfoam® into the direct contact with the round window membrane. In our experience, the latter is an easy, safe and atraumatic technique to deliver gene into the cochlea. A number of different gene transfer vectors have been investigated in vivo for their efficacy, utility and safety in intracochlear gene transfer. Vectors successfully studied include cationic liposomes, adeno-associated virus, adenovirus, lentivirus, herpes simplex virus and vaccinia virus. While the viral vectors offer clear experimental advantages, human gene therapy in the future will likely utilize nonviral vectors to maximize safety. Finally, safety issues regarding dissemination of gene transfer vectors beyond the target cochlea will need to be adequately addressed.

Keywords:
Cochlear gene therapy, Viral vectors, Osmotic minipump, Microinjection, Round window membrane
1.
Carvalho GJ, Lalwani AK: Effect of cochleostomy and intracochlear infusion on auditory brainstem response thresholds in the guinea pig. Am J Otol 1999;20:87–90.
2.
Davies E, Gladstone HB, Williams H, Hradek G, Shah SB, Schindler RA: A model for long-term intracochlear administration of pharmacologic agents. Am J Otol 1994;15:757–761.
3.
Derby ML, Sena-Esteves M, Breakefield XO, Corey DP: Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res 1999;134:1–8.
4.
Han JJ, Mhatre AN, Wareing M, Pettis R, Zufferey AN, Trono D, Lalwani AK: Transgene expression in the guinea pig cochlea mediated by the lentivirus derived gene transfer vector. Hum Gene Ther 1999;10:1867–1874.
5.
Jero J, Mhatre AN, Tseng CJ, Stern RE, Coling D, Goldstein JA, Hong K, Zheng WW, Hoque S, Lalwani AK: Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther 2001a;12:539–548.
6.
Jero J, Tseng CJ, Mhatre AN, Lalwani AK: A surgical approach appropriate for targeted cochlear gene therapy in the mouse. Hear Res 2001b;151:106–114.
7.
Kho ST, Pettis RM, Mhatre AN, Lalwani AK: Safety of adeno associated virus as cochlear gene transfer vector: Analysis of distant spread beyond injected cochleae. Mol Ther 2000a;2:368–373.
8.
Kho ST, Pettis RM, Mhatre AN, Lalwani AK: Cochlear microinjection and its effect upon auditory function. Eur Arch Otorhinolaryngol 2000b;257:469–472.
9.
Komeda M, Roessler BJ, Raphael Y: The influence of interleukin-1 receptor antagonist transgene on spiral ganglion neurons. Hear Res 1999;131:1–10.
10.
Lalwani AK, Han JJ, Walsh BJ, Zolotukhin S, Muzyczka N, Mhatre AN: Green fluorescent protein as a reporter for gene transfer studies into the cochlea of a guinea pig. Hear Res 1997;114:139–147.
11.
Lalwani AK, Walsh BJ, Carvalho GJ, Muzyczka N, Mhatre AN: Expression of adeno-associated virus (AAV) integrated transgene within the mammalian vestibular organs. Am J Otol 1998a;19:390–395.
12.
Lalwani AK, Walsh BJ, Reilly PG, Carvalho GJ, Zolotukhin S, Muzyczka N, Mhatre AN: Long term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Ther 1998b;5:277–281.
13.
Lalwani AK, Walsh B, Reilly PG, Muzyska N, Mhatre A: Development of in vivo gene therapy for hearing disorders: Introduction of adeno-associated virus into the guinea pig cochlea. Gene Ther 1996;3:588–592.
14.
Muzyczka N: Use of adeno-associated virus as a general transduction vector for mammalian
15.
cells. Curr Top Microbiol Immunol 1992;158:97–129.
16.
Naldini L, Blomer U, Gage FH, Trono D, Verma IM: Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996a;93:11382–11388.
17.
Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996b;272:263–267.
18.
Raphael Y, Frisancho JC, Roessler BJ: Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci Lett 1996;207:137–141.
19.
Wareing M, Mhatre AN, Han JJ, Pettis RM, Hong K, Zheng WW, Lalwani AK: Cationic liposome mediated transgene expression in the guinea pig cochlea. Hear Res 1999;128:61–69.
20.
Yagi M, Magal E, Sheng Z, Ang KA, Raphael Y: Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Hum Gene Ther 1999;10:813–823.
21.
Yamasoba T, Yagi M, Roessler BJ, Miller JM, Raphael Y: Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac. Hum Gene Ther 1999;10:769–774.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.